Skip to content

Hirundo Biosciences

Judicial reorganisation
Public limited companyfounded 2017active for 9 yearsBoulevard de Patience et Beaujonc 3, 4000 Liège, Belgium46 active companies are registered at this addressKBO/BCE: BE 0681.855.065
Summary

The file of Hirundo Biosciences contains 5 judicial reorganisation notices, as published in the Belgian Official Gazette. During the judicial reorganisation Checked does not compute a bankruptcy probability from the figures: of the Belgian companies that opened one in 2023 and 2024, about one in four went bankrupt within twelve months. The 2025 annual accounts show negative equity (-€548,240) and a net result of -€13.7m. Equity is shrinking by about 19% per year across the filed financial years. Its solvency ranks better than 7% of 5,697 sector peers (NACE 68, financial year 2025).

Hirundo BiosciencesJudicial reorganisationChecked score 3/100

Are you a creditor?

Judicial reorganisation Source: Belgian Official Gazette

Your claim still exists, but while the moratorium runs you cannot enforce it. What you do now depends on the track of the reorganisation.

The procedure

Court
Enterprise Court of Liège
Opened
4 April 2023
Track
Reorganisation by collective agreement
Docket number
20230014
Moratorium until
4 April 2024 (passed; an extension would be in a later judgment)
Creditors' vote
26 March 2024
Delegated judge
Jacques Leboutte
Official Gazette
11-04-2023 (pdf) ↗search the document for 2023/113702

What to do now

  1. Do not attach assets or start enforcement for debts from before the opening while the moratorium runs.
  2. Check the amount the company lists you for: it has to tell you. If it is wrong, dispute it in writing.
  3. The company files a reorganisation plan and creditors vote on it at a hearing. A plan approved and confirmed by the court also binds those who voted against.
  4. What you deliver after the opening is not covered by the moratorium: agree clear payment terms.
  5. The file is in RegSol, where you can read the documents of the procedure.

Deadlines: the judgment sets how long the moratorium runs. That date is in RegSol and in the publication in the Official Gazette. The date of the vote on the plan is in the judgment and in RegSol.

View the file in RegSol ↗ Follow Follow this reorganisation: you are alerted to an extension, the court's approval, the closure or a bankruptcy.

General information, not legal advice. If in doubt, your lawyer or your accountant can help.Creditor guide for this company

Embed in an article

Writing about this reorganisation? Embed the Hirundo Biosciences company card in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.

Preview
The preview appears here.
  • Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
  • Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
  • Where scripts do not run (a newsletter, a feed reader) a plain link remains.

Overview

Activity
Buying and selling of own real estate
NACE 68110Other research and development on natural sciences NACE 72109
10th largest employer in Liège, Real estate sector1 site
Size
€0turnover 2025
Staff
12.2 FTE
Equity
-€548,240
Loss
-€13.7m
Financial health
3 Critical Checked score 2025
Reorganisation running: about 1 in 4 bankrupt within the year
Structure
Parent
Chemical Works of Gedeon Richter Plc
Holdings
1
Accounts 7 days early7 of 17 deeds read
Signalsraises riskNegative equityIn judicial reorganisationneutralLatest accounts filed on timeShow the evidence

Checked score

Score 2025
3 / 100
Critical
Without a bankruptcy probability: score from the figures alone
Financial strength · tick = 2024
Weak
Solvency 9-42
equity -16.1% of total assets
Liquidity 0-20
short-term debt 115.4%
Profitability 0=
return on assets -402.0%
Bankruptcy probability, 12 months

Judicial reorganisation

About 1 in 4 comparable companies went bankrupt within the year

A judicial reorganisation is open: we then compute no probability from the figures. Measured over every Belgian company in an open or failed reorganisation: 25% to 26% bankrupt within twelve months (2024 and 2025).

No credit on open account during an ongoing judicial reorganisation
Liquidity insufficient (current ratio 0.26, compared with 0.11 in 2024, below 1; short-term debt: 115.4% of total assets), and equity is negative.

Signals

Three signals.
raises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€548,240
raises risk · In judicial reorganisation
Ongoing procedure under court protection (Book XX of the Code of Economic Law). The company is restructuring.
Belgian Official Gazette
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
7 days early
2024
8 days late
2023
21 days late
2022
5 days early
2021
31 days late
2020
9 days late
2019
3 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days after the deadline; the sector median (NACE 68) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
16-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: László Kovács (director)Appointments: Imre Bencze, András Trompler…
  2. Annual accounts filedfinancial year 2025 · full…
  3. Board meeting · Transfer of a…Gazette deed

Key points

  • Risk: In judicial reorganisationtrustee not known 04-04-2023 View
  • Risk: Negative equityfinancial year 2025: debts exceed assets -€548,240 View
  • Risk: 8 loss-making years in a rowloss financial year 2025 -€13.7m View
  • Caution: Turnover fell in 2025from €277,707 to €0 ▼ 100% View
  • Caution: Among the weakest 5% on net resultsector median €20,738 · 5,703 companies -€13.7m View
  • Board changedlatest change 27-08-2026 · 2 in office 3 joined · 1 left View
  • Controlled by Chemical Works of Gedeon…the company in turn controls 1 companies parent View

By topic

Financials

Financial year
2025
Turnover
€0
Loss
-€13.7m
Solvency
-16.1%
Turnover▼ 100%
Net result
20242025
Go to Financials

Board & ownership

Board
2 members
Parent
Chemical Works of Gedeon…
  • András TromplerDirector
  • Imre BenczeDirector
Go to Board & ownership

Timeline

Events
21
Since
2019
Next accounts
by 31-07-2027
  1. 26-01-2026Capital & shares · Amendment of the…
  2. 31-12-2025Weakest financial year
  3. 15-12-2025Registered office · Miscellaneous
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Buying and selling of own real estateNACE 68110
Founded
28-09-2017
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Investigating this company? Keep it with today's facts in a case file.